tetano
Editor, Senior Moderator
J Nucl Med
. 2021 May 20;jnumed.120.256099.
doi: 10.2967/jnumed.120.256099. Online ahead of print.
Post-infectious neurologic complications in Covid-2019: a complex case report
Pietro Tiraboschi[SUP] 1 [/SUP], Rubjona Xhani[SUP] 2 [/SUP], Simone Maria Zerbi[SUP] 3 [/SUP], Angelo Corso[SUP] 4 [/SUP], Isabella Martinelli[SUP] 4 [/SUP], Laura Fusi[SUP] 2 [/SUP], Giampiero Grampa[SUP] 2 [/SUP], Andrea Lombardo[SUP] 3 [/SUP], Paola Cavalcante[SUP] 5 [/SUP], Cristina Cappelletti[SUP] 5 [/SUP], Francesca Andreetta[SUP] 5 [/SUP], Alberto Sironi[SUP] 6 [/SUP], Alberto Redolfi[SUP] 7 [/SUP], Cristina Muscio[SUP] 1 [/SUP]
Affiliations
Abstract
A 40-year-old woman with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection developed neurologic manifestations (confusion, agitation, seizures, dyskinesias, and parkinsonism) few weeks after SARS onset. Magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) analyses were unremarkable, but an [SUP]18[/SUP]F-Fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) showed limbic and extra-limbic hypermetabolism. A full recovery, alongside FDG normalization in previously hypermetabolic areas, was observed after intravenous immunoglobulin (IVIg) administration.
Keywords: COVID-19; IVIg; Infectious Disease; Neurology; PET; SARS-CoV-2; encephalitis; neuroimaging.
. 2021 May 20;jnumed.120.256099.
doi: 10.2967/jnumed.120.256099. Online ahead of print.
Post-infectious neurologic complications in Covid-2019: a complex case report
Pietro Tiraboschi[SUP] 1 [/SUP], Rubjona Xhani[SUP] 2 [/SUP], Simone Maria Zerbi[SUP] 3 [/SUP], Angelo Corso[SUP] 4 [/SUP], Isabella Martinelli[SUP] 4 [/SUP], Laura Fusi[SUP] 2 [/SUP], Giampiero Grampa[SUP] 2 [/SUP], Andrea Lombardo[SUP] 3 [/SUP], Paola Cavalcante[SUP] 5 [/SUP], Cristina Cappelletti[SUP] 5 [/SUP], Francesca Andreetta[SUP] 5 [/SUP], Alberto Sironi[SUP] 6 [/SUP], Alberto Redolfi[SUP] 7 [/SUP], Cristina Muscio[SUP] 1 [/SUP]
Affiliations
- PMID: 34016729
- DOI: 10.2967/jnumed.120.256099
Abstract
A 40-year-old woman with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection developed neurologic manifestations (confusion, agitation, seizures, dyskinesias, and parkinsonism) few weeks after SARS onset. Magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) analyses were unremarkable, but an [SUP]18[/SUP]F-Fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) showed limbic and extra-limbic hypermetabolism. A full recovery, alongside FDG normalization in previously hypermetabolic areas, was observed after intravenous immunoglobulin (IVIg) administration.
Keywords: COVID-19; IVIg; Infectious Disease; Neurology; PET; SARS-CoV-2; encephalitis; neuroimaging.